Company Filing History:
Years Active: 2015-2017
Title: Bruno François Marie Delest: Innovator in HIV Research
Introduction
Bruno François Marie Delest is a notable inventor based in Rouen, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit HIV replication. His work has led to the filing of multiple patents, showcasing his innovative approach to tackling critical health issues.
Latest Patents
Delest holds 2 patents related to HIV-inhibiting compounds. His latest patents focus on 5-amido substituted pyrimidines, which are derivatives that exhibit properties capable of inhibiting the replication of the Human Immunodeficiency Virus (HIV). These inventions not only detail the chemical formulas of these pyrimidine derivatives but also encompass their preparation and the pharmaceutical compositions that include these compounds.
Career Highlights
Throughout his career, Delest has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Janssen R&D Ireland and Janssen Sciences Ireland UC. His experience in these organizations has allowed him to contribute to significant advancements in HIV research and treatment.
Collaborations
Delest has collaborated with esteemed colleagues in his field, including Jerôme Emile Georges Guillemont and Mikaël Paugam. These partnerships have further enriched his research and development efforts, leading to innovative solutions in combating HIV.
Conclusion
Bruno François Marie Delest is a distinguished inventor whose work in HIV research has resulted in valuable patents and collaborations. His contributions continue to play a vital role in the fight against HIV, showcasing the importance of innovation in the pharmaceutical industry.